Education
About Us
Working with TipRanks
Follow Us
David R Pelizzon Insider Profile
4 Followers
David R Pelizzon, Director at OrthoPediatrics, holds 10.99M shares in Alphatec Holdings (Ticker: ATEC), holds 6.93M shares in OrthoPediatrics (Ticker: KIDS). Most recently, David R Pelizzon Sold ― shares of Alphatec Holdings on Dec 10, 2025 for an estimated value of $5.30M.
Profitable Transactions
5 out of 13 Profitable Transactions
Average Return
+17.40%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that David R Pelizzon holds in companies
Most Profitable Insider Trade
The most profitable trade made by David R Pelizzon
David R Pelizzon's Trading History
OrthoPediatrics
May 28, 2025
Director
Uninformative Buy
―
$130.30M
Alphatec Holdings
Dec 10, 2025
Director, Ten Percent Owner
Informative Sell
5.30M
$229.73M
List of latest transactions for each holding click on a transaction to see David R Pelizzon's performance on stock
You May Also Like
David R Pelizzon insider profile FAQ
What is the percentage of profitable transactions made by David R Pelizzon?
The percentage of profitable transactions made by David R Pelizzon is 38%.
What is the average return per transaction made by David R Pelizzon?
The average return per transaction made by David R Pelizzon is 17.40%.
What stocks does David R Pelizzon hold?
David R Pelizzon holds: KIDS, ATEC stocks.
What was David R Pelizzon’s latest transaction?
David R Pelizzon latest transaction was an Informative Sell of $5.30M.
What was David R Pelizzon's most profitable transaction?
David R Pelizzon’s most profitable transaction was an Informative Buy of ATEC stock on August 26, 2024. The return on the trade was 170.20%.
What is David R Pelizzon's role in OrthoPediatrics?
David R Pelizzon's role in OrthoPediatrics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.